Article info

other Versions

Download PDFPDF
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

Authors

  1. Correspondence to Dr Kara Long Roche, Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA; longrock{at}mskcc.org
View Full Text

Citation

Liu YL, Zhou QC, Iasonos A, et al
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

Publication history

  • Received May 20, 2020
  • Revision received July 15, 2020
  • Accepted July 17, 2020
  • First published October 26, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.